BRIEF-ESSA Pharma Amends Agreement with XenoTherapeutics

Reuters09-24

BRIEF-<a href="https://laohu8.com/S/EPIX">ESSA Pharma</a> Amends Agreement with XenoTherapeutics

Sept 24 (Reuters) - ESSA Pharma Inc EPIX.O:

ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICS
ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHARE
ESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHARE
ESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDER
ESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025

Source text: ID:nCNW5cfYQa

Further company coverage: EPIX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2569777779?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-24 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569777779","market":"us","top_or_hot":-1,"title":"BRIEF-ESSA Pharma Amends Agreement with XenoTherapeutics","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EPIX\">ESSA Pharma</a> Amends Agreement with XenoTherapeutics</title></head><body><p><span>Sept 24 (Reuters)</span><span> - </span>ESSA Pharma Inc <span>EPIX.O</span>:</p><ul><li><p>ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICS</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHARE</p></li><li><p>ESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHARE</p></li><li><p>ESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDER</p></li><li><p>ESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025</p></li></ul><p>Source text: <span>ID:nCNW5cfYQa</span></p><p>Further company coverage: <span>EPIX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-ESSA Pharma Amends Agreement with XenoTherapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-ESSA Pharma Amends Agreement with XenoTherapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-24 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EPIX\">ESSA Pharma</a> Amends Agreement with XenoTherapeutics</title></head><body><p><span>Sept 24 (Reuters)</span><span> - </span>ESSA Pharma Inc <span>EPIX.O</span>:</p><ul><li><p>ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICS</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHARE</p></li><li><p>ESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHARE</p></li><li><p>ESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDER</p></li><li><p>ESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025</p></li></ul><p>Source text: <span>ID:nCNW5cfYQa</span></p><p>Further company coverage: <span>EPIX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nTUA5HKDZT:1","article_id":"2569777779","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569777779","pubTimestamp":1758708395,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-ESSA Pharma Amends Agreement with XenoTherapeuticsSept 24 (Reuters) - ESSA Pharma Inc EPIX.O:ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICSESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.1","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","XOMA":"标记临床研究","EPIX":"ESSA Pharma Inc."},"translate_title":"简介-ESSA Pharma修改与XenoTherapeutics的协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XOMA":0.9,"EPIX":0.9},"content_text":"BRIEF-ESSA Pharma Amends Agreement with XenoTherapeuticsSept 24 (Reuters) - ESSA Pharma Inc EPIX.O:ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICSESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHAREESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHAREESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDERESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025Source text: ID:nCNW5cfYQaFurther company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2569777779","isCrawlerRequest":true}